Treatment of spondyloarthritis beyond TNF-alpha blockade
- Author
- Filip Van den Bosch (UGent) and Atul Deodhar
- Organization
- Keywords
- Psoriatic arthritis, Spondyloarthritis, Axial spondyloarthritis, Ankylosing spondylitis, Anti-TNF failure, Ustekinumab, Anti-interleukin-17 agents, Apremilast, PLACEBO-CONTROLLED TRIAL, ACTIVE PSORIATIC-ARTHRITIS, ANTI-INTERLEUKIN-17A MONOCLONAL-ANTIBODY, ORAL PHOSPHODIESTERASE-4 INHIBITOR, PROOF-OF-CONCEPT, DOUBLE-BLIND, ANKYLOSING-SPONDYLITIS, PLAQUE PSORIASIS, IL-17 RECEPTOR, OPEN-LABEL
Downloads
-
(...).pdf
- full text
- |
- UGent only
- |
- |
- 652.67 KB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-7024341
- MLA
- Van den Bosch, Filip, and Atul Deodhar. “Treatment of Spondyloarthritis beyond TNF-Alpha Blockade.” BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, vol. 28, no. 5, 2014, pp. 819–27, doi:10.1016/j.berh.2014.10.019.
- APA
- Van den Bosch, F., & Deodhar, A. (2014). Treatment of spondyloarthritis beyond TNF-alpha blockade. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 28(5), 819–827. https://doi.org/10.1016/j.berh.2014.10.019
- Chicago author-date
- Van den Bosch, Filip, and Atul Deodhar. 2014. “Treatment of Spondyloarthritis beyond TNF-Alpha Blockade.” BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY 28 (5): 819–27. https://doi.org/10.1016/j.berh.2014.10.019.
- Chicago author-date (all authors)
- Van den Bosch, Filip, and Atul Deodhar. 2014. “Treatment of Spondyloarthritis beyond TNF-Alpha Blockade.” BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY 28 (5): 819–827. doi:10.1016/j.berh.2014.10.019.
- Vancouver
- 1.Van den Bosch F, Deodhar A. Treatment of spondyloarthritis beyond TNF-alpha blockade. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY. 2014;28(5):819–27.
- IEEE
- [1]F. Van den Bosch and A. Deodhar, “Treatment of spondyloarthritis beyond TNF-alpha blockade,” BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, vol. 28, no. 5, pp. 819–827, 2014.
@article{7024341,
author = {{Van den Bosch, Filip and Deodhar, Atul}},
issn = {{1521-6942}},
journal = {{BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY}},
keywords = {{Psoriatic arthritis,Spondyloarthritis,Axial spondyloarthritis,Ankylosing spondylitis,Anti-TNF failure,Ustekinumab,Anti-interleukin-17 agents,Apremilast,PLACEBO-CONTROLLED TRIAL,ACTIVE PSORIATIC-ARTHRITIS,ANTI-INTERLEUKIN-17A MONOCLONAL-ANTIBODY,ORAL PHOSPHODIESTERASE-4 INHIBITOR,PROOF-OF-CONCEPT,DOUBLE-BLIND,ANKYLOSING-SPONDYLITIS,PLAQUE PSORIASIS,IL-17 RECEPTOR,OPEN-LABEL}},
language = {{eng}},
number = {{5}},
pages = {{819--827}},
title = {{Treatment of spondyloarthritis beyond TNF-alpha blockade}},
url = {{http://doi.org/10.1016/j.berh.2014.10.019}},
volume = {{28}},
year = {{2014}},
}
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: